RNS Number : 1784K
Genus PLC
20 April 2020
20 April 2020
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that
Daniel Hartley, Group General Counsel and Company Secretary
and member of the Genus Executive Leadership Team ('GELT'), sold 7,500 ordinary shares in the Company on 17 April 2020 on the London Stock Exchange at a price of 3,610 pence per share.
The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of ordinary shares sold.
For further information please contact:
Genus:
Vaughn Walton, Deputy Company Secretary Tel: +44 (0)1256 347100
Table A - GELT Private Share Sale
|
1.
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a.
|
Name
|
Daniel Hartley
|
|
2.
|
Reason for the notification
|
|
a.
|
Position/status
|
Group General Counsel and Company Secretary
|
|
b.
|
Initial notification
/Amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Genus plc
|
|
b.
|
LEI
|
54930022EOITNKSIGH56
|
|
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a.
|
Description of the
Financial instrument, type of instrument
Identification code
|
Ordinary shares of 10p each
GB0002074580
|
|
b.
|
Nature of the transaction
|
Sale of 7,500 ordinary shares.
|
|
c.
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
3,610p
|
7,500
|
|
|
d.
|
Aggregated information
·
Aggregated volume
·
Price
|
|
Average price(s)
|
Total volume(s)
|
|
3,610p
|
7,500
|
|
|
e.
|
Date of the transaction
|
2020-04-17
|
|
f.
|
Place of the transaction
|
London Stock Exchange, Main Market (XLON)
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHURUWRRNUSURR